Suppr超能文献

上海 SARS-CoV-2 奥密克戎感染者淋巴细胞与中性粒细胞计数下降,C 反应蛋白和血清淀粉样蛋白 A 无明显变化。

"Lymphocyte * Neutrophil" count decreased in SARS-CoV-2 Omicron patients in Shanghai with no significant change in CRP and SAA.

机构信息

Department of Laboratory Medicine,Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Meadicine, Shanghai, China.

Teaching Laboratory Center of Medicine, School of Medicine, Tongji University, Shanghai, China.

出版信息

J Clin Lab Anal. 2022 Oct;36(10):e24671. doi: 10.1002/jcla.24671. Epub 2022 Aug 21.

Abstract

BACKGROUND

At present, there is a new variant Omicron BA.2 of SARS-CoV-2. In some previous studies, it was found that CBC, NLR, CRP, SAA, etc. in patients with SARS-CoV-2 had a series of changes, which were significantly correlated with the diagnosis and prognosis of patients. Therefore, in order to find specific diagnostic indicators, we explore the changes in these blood indicators and inflammatory indicators in patients with the SARS-CoV-2 Omicron.

METHODS

A total of 127 Omicron confirmed patients who had visited fever clinic was selected as the positive group, and 75 Omicron excluded patients were selected as the negative group. We collected and analyzed the CBC, CRP, SAA test data, and clinical data of all subjects for analysis and statistics.

RESULTS

WBC, NEU, LYM, EOS, PLT, PCT, LYM * NEU count compared with the negative group were significantly lower (p < 0.05); on the contrary, CNR were significantly higher (p < 0.05); The levels of CRP and SAA were not significantly different from those of the negative group (p > 0.05); the AUC of 0.781 for the diagnosis of LYM * NEU with an optimal cutoff value of 5.79, with a sensitivity and specificity of 68% and 73%, respectively, Youden index of 0.41, giving the best diagnostic performance.

CONCLUSION

The decreased LYM * NEU count can be used as the early, rapid, and accurate diagnostic indicator for Omicron. While due to the attenuated toxicity of BA.2 sublineage, CRP and SAA had no significance in the differential diagnosis of confirmed patients.

摘要

背景

目前,SARS-CoV-2 出现了新的变异株奥密克戎 BA.2。在之前的一些研究中发现,SARS-CoV-2 患者的 CBC、NLR、CRP、SAA 等有一系列变化,与患者的诊断和预后有显著相关性。因此,为了寻找特异性诊断指标,我们探索了 SARS-CoV-2 奥密克戎患者这些血液指标和炎症指标的变化。

方法

选取就诊发热门诊的 127 例奥密克戎确诊患者作为阳性组,选取 75 例奥密克戎排除患者作为阴性组。收集并分析所有患者的 CBC、CRP、SAA 检验数据及临床资料进行分析统计。

结果

WBC、NEU、LYM、EOS、PLT、PCT、LYMNEU 计数与阴性组相比均显著降低(p<0.05);相反,CNR 显著升高(p<0.05);CRP 和 SAA 水平与阴性组相比无显著差异(p>0.05);LYMNEU 的 AUC 为 0.781,最佳截断值为 5.79,灵敏度和特异性分别为 68%和 73%,Youden 指数为 0.41,具有最佳诊断性能。

结论

降低的 LYM*NEU 计数可作为奥密克戎早期、快速、准确的诊断指标。而由于 BA.2 亚系毒性减弱,CRP 和 SAA 在确诊患者的鉴别诊断中无意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94e2/9550959/c212af2572cc/JCLA-36-e24671-g002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验